New Haven biotech Arvinas, Pfizer in billion-dollar deal for breast cancer drug
"We share Pfizer's deep commitment to people with breast cancer and are thrilled to partner with them to develop this potentially best-in-class therapy," Arvinas' CEO said. |!| New…
